185 related articles for article (PubMed ID: 30118852)
1. Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1.
Cespedes MS; Kang M; Kojic EM; Umbleja T; Godfrey C; Webster-Cyriaque JY; Masih R; Firnhaber C; Grinsztejn B; Saah A; Cu-Uvin S; Aberg JA
Papillomavirus Res; 2018 Dec; 6():15-21. PubMed ID: 30118852
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the Quadrivalent HPV Vaccine in Preventing Anal ≥ HSILs in a Spanish Population of HIV+ MSM Aged > 26 Years.
Hidalgo-Tenorio C; Pasquau J; Omar-Mohamed M; Sampedro A; López-Ruz MA; López Hidalgo J; Ramírez-Taboada J
Viruses; 2021 Jan; 13(2):. PubMed ID: 33498165
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).
Hidalgo-Tenorio C; Ramírez-Taboada J; Gil-Anguita C; Esquivias J; Omar-Mohamed-Balgahata M; SamPedro A; Lopez-Ruz M; Pasquau J
AIDS Res Ther; 2017 Jul; 14(1):34. PubMed ID: 28720147
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.
Kojic EM; Kang M; Cespedes MS; Umbleja T; Godfrey C; Allen RT; Firnhaber C; Grinsztejn B; Palefsky JM; Webster-Cyriaque JY; Saah A; Aberg JA; Cu-Uvin S
Clin Infect Dis; 2014 Jul; 59(1):127-35. PubMed ID: 24723284
[TBL] [Abstract][Full Text] [Related]
5. High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Individuals Older Than 26 Years: ACTG 5298.
Cranston RD; Cespedes MS; Paczuski P; Yang M; Coombs RW; Dragavon J; Saah A; Godfrey C; Webster-Cyriaque JY; Chiao EY; Bastow B; Wilkin T;
Sex Transm Dis; 2018 Apr; 45(4):266-271. PubMed ID: 29528986
[TBL] [Abstract][Full Text] [Related]
6. The effect of history of abnormal pap smear or preceding HPV infection on the humoral immune response to Quadrivalent Human Papilloma virus (qHPV) vaccine in women with systemic lupus erythematosus.
Dhar JP; Essenmacher L; Dhar R; Magee A; Ager J; Sokol RJ
Hum Vaccin Immunother; 2018; 14(9):2318-2322. PubMed ID: 29708835
[TBL] [Abstract][Full Text] [Related]
7. HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine.
Money DM; Moses E; Blitz S; Vandriel SM; Lipsky N; Walmsley SL; Loutfy M; Trottier S; Smaill F; Yudin MH; Klein M; Harris M; Cohen J; Wobeser W; Bitnun A; Lapointe N; Samson L; Brophy J; Karatzios C; Ogilvie G; Coutlée F; Raboud J;
Vaccine; 2016 Sep; 34(40):4799-806. PubMed ID: 27544584
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.
Sankaranarayanan R; Prabhu PR; Pawlita M; Gheit T; Bhatla N; Muwonge R; Nene BM; Esmy PO; Joshi S; Poli UR; Jivarajani P; Verma Y; Zomawia E; Siddiqi M; Shastri SS; Jayant K; Malvi SG; Lucas E; Michel A; Butt J; Vijayamma JM; Sankaran S; Kannan TP; Varghese R; Divate U; Thomas S; Joshi G; Willhauck-Fleckenstein M; Waterboer T; Müller M; Sehr P; Hingmire S; Kriplani A; Mishra G; Pimple S; Jadhav R; Sauvaget C; Tommasino M; Pillai MR;
Lancet Oncol; 2016 Jan; 17(1):67-77. PubMed ID: 26652797
[TBL] [Abstract][Full Text] [Related]
9. AIDS Malignancy Consortium 054: Safety and Immunogenicity of the Quadrivalent Vaccine in Indian Women Living With HIV.
Palefsky JM; Poongulali S; Lensing S; Lee J; Da Costa M; Chein A; Beulah F; Murugavel KG; Kumarasamy N
J Acquir Immune Defic Syndr; 2021 Jun; 87(2):875-881. PubMed ID: 33587509
[TBL] [Abstract][Full Text] [Related]
10. Quadrivalent HPV vaccine in HIV-1-infected early adolescent girls and boys in Kenya: Month 7 and 12 post vaccine immunogenicity and correlation with immune status.
Mugo NR; Eckert L; Magaret AS; Cheng A; Mwaniki L; Ngure K; Celum C; Baeten JM; Galloway DA; Wamalwa D; Wald A
Vaccine; 2018 Nov; 36(46):7025-7032. PubMed ID: 30297124
[TBL] [Abstract][Full Text] [Related]
11. Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.
Levin MJ; Huang S; Moscicki AB; Song LY; Read JS; Meyer WA; Saah AJ; Richardson K; Weinberg A;
Vaccine; 2017 Mar; 35(13):1712-1720. PubMed ID: 28238631
[TBL] [Abstract][Full Text] [Related]
12. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
Huh WK; Joura EA; Giuliano AR; Iversen OE; de Andrade RP; Ault KA; Bartholomew D; Cestero RM; Fedrizzi EN; Hirschberg AL; Mayrand MH; Ruiz-Sternberg AM; Stapleton JT; Wiley DJ; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Cuzick J; Garland SM; Kjaer SK; Bautista OM; Haupt R; Moeller E; Ritter M; Roberts CC; Shields C; Luxembourg A
Lancet; 2017 Nov; 390(10108):2143-2159. PubMed ID: 28886907
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa.
Mugo N; Ansah NA; Marino D; Saah A; Garner EI
Hum Vaccin Immunother; 2015; 11(6):1323-30. PubMed ID: 25912475
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN Study.
Kojic EM; Conley L; Bush T; Cu-Uvin S; Unger ER; Henry K; Hammer J; Escota G; Darragh TM; Palefsky JM; Brooks JT; Patel P
J Infect Dis; 2018 Apr; 217(10):1544-1552. PubMed ID: 29452366
[TBL] [Abstract][Full Text] [Related]
15. A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.
Wilkin TJ; Chen H; Cespedes MS; Leon-Cruz JT; Godfrey C; Chiao EY; Bastow B; Webster-Cyriaque J; Feng Q; Dragavon J; Coombs RW; Presti RM; Saah A; Cranston RD
Clin Infect Dis; 2018 Oct; 67(9):1339-1346. PubMed ID: 29659751
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Anal Human Papillomavirus Vaccine Types in the Bangkok Men Who Have Sex With Men Cohort Study.
Cranston RD; Althouse AD; van Griensven F; Janocko L; Curlin ME; Chaikummao S; Chonwattana W; Siegel A; Holtz TH; McGowan I
Sex Transm Dis; 2015 Dec; 42(12):671-6. PubMed ID: 26562695
[TBL] [Abstract][Full Text] [Related]
17. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).
Kojic EM; Cu-Uvin S; Conley L; Bush T; Onyekwuluje J; Swan DC; Unger ER; Henry K; Hammer JH; Overton ET; Darragh TM; Palefsky JM; Vellozzi C; Patel P; Brooks JT
Sex Transm Dis; 2011 Apr; 38(4):253-9. PubMed ID: 20966828
[TBL] [Abstract][Full Text] [Related]
19. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.
Ährlund-Richter A; Cheng L; Hu YOO; Svensson M; Pennhag AAL; Ursu RG; Haeggblom L; Grün N; Ramqvist T; Engstrand L; Dalianis T; Du J
Front Cell Infect Microbiol; 2019; 9():59. PubMed ID: 30949454
[No Abstract] [Full Text] [Related]
20. Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth.
Moscicki AB; Karalius B; Tassiopoulos K; Yao TJ; Jacobson DL; Patel K; Purswani M; Seage GR;
Clin Infect Dis; 2019 Sep; 69(7):1183-1191. PubMed ID: 30927547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
